Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets (Q38170539)

30 August 2017

Effect of probiotics on biomarkers of cardiovascular disease: implications for heart-healthy diets (English)

1 reference

30 August 2017

0 references

0 references

cardiovascular disease

1 reference

Douglas B DiRienzo

1

1 reference

30 August 2017

13 December 2013

1 reference

30 August 2017

1 reference

30 August 2017

72

1 reference

30 August 2017

1

1 reference

30 August 2017

18-29

1 reference

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

30 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Probiotics and their fermented food products are beneficial for health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Promise of low-density lipoprotein-lowering therapy for primary and secondary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

The evidence for dietary prevention and treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Gut microbiota in obesity and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Human gut microbiota and its relationship to health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

The effects of probiotic and conventional yoghurt on lipid profile in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

The effect of a probiotic milk product on plasma cholesterol: a meta-analysis of short-term intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Lactobacillus gasseri [corrected] CHO-220 and inulin reduced plasma total cholesterol and low-density lipoprotein cholesterol via alteration of lipid transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Effects of a milk product, fermented by Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Probiotic capsules do not lower plasma lipids in young women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

A double-blind placebo-controlled study of the effects of Lactobacillus acidophilus on plasma lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Effects of consumption of probiotics and prebiotics on serum lipid levels in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Gut microbiota and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Bile acid-activated receptors in the treatment of dyslipidemia and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

A G protein-coupled receptor responsive to bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Beneficial health effects of milk and fermented dairy products--review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Scientific Opinion on the substantiation of a health claim related to 3 g/day plant sterols/stanols and lowering blood LDL-cholesterol and reduced risk of (coronary) heart disease pursuant to Article 19 of Regulation (EC) No 1924/2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Role of phytosterols in lipid-lowering: current perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Plant sterols/stanols as cholesterol lowering agents: A meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Mechanisms underlying the cholesterol-lowering properties of soluble dietary fibre polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Scientific Opinion on the substantiation of a health claim related to oat beta glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Scientific Opinion on the substantiation of a health claim related to barley beta-glucans and lowering of blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Safety and Tolerance of Lactobacillus reuteri in Healthy Adult Male Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Scientific Opinion on the maintenance of the list of QPS microorganisms intentionally added to food or feed (2009 update)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Safety of D(-)-lactic acid producing bacteria in the human infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Safety assessment of dairy microorganisms: the Enterococcus genus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

Enterococci as probiotics and their implications in food safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FNURE.12084

21 January 2018

Identifiers

DOI

10.1111/NURE.12084

1 reference

30 August 2017

1 reference

PubMed ID

24330093